在人类中进行的第1阶段1/2mRNA试验中进行的酸性血的中间分析
Dwight Koeberl1, Andreas Schulze2, Neal Sondheimer2
1Duke University School of Medicine, Durham, NC, USA.
Nature
|April 3, 2024
概括
这项研究评估了mRNA-3927,一种用于酸血症的新疗法. 初步结果显示,代谢失补偿事件减少了70%,表明潜在的治疗益处.
科学领域:
- 生物化学
- 遗传学
- 药理学
背景情况:
- 酸血症是一种罕见的遗传代谢疾病.
- 由甲酶A碳酸酶 (PCCA或PCCB) 子单元的缺陷引起的.
- 导致有毒代谢物的积累和危及生命的脱补偿事件.
研究的目的:
- 评估双重mRNA治疗的mRNA-3927的安全性和有效性.
- mRNA-3927编码了PCCA和PCCB的子单位.
- 一个阶段1/2,开放标签,剂量优化研究的中间分析.
主要方法:
- 第一次对mRNA-3927进行人体研究.
- 在5个剂量队列中招募了16名参与者.
- 在15. 69人年内静脉注射mRNA-3927.
主要成果:
- 没有观察到剂量限制性毒性.
- 在93. 8%的参与者中出现治疗引起的不良事件.
- 初步分析显示剂量依赖的暴露和70%的代谢失补偿事件减少.
结论:
- 在早期试验中,mRNA-3927显示出良好的安全性.
- 初步的疗效表明,代谢失补偿事件显著减少.
- 需要进一步的研究来证实酸血的治疗潜力.
相关概念视频
Phase II Reactions: Acetylation Reactions
Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...


